SCHEMBL18901202

SCHEMBL18901202

O=Cc1ccc2c(c1)oc(=O)c1cnccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ROCK2 O75116 2/20 0.46
▸ PDE2A O00408 1/20 0.41
▸ NPSR1 Q6W5P4 2/20 0.39
▸ RXFP1 Q9HBX9 2/20 0.39
▸ ALDH1A1 P00352 4/20 0.38
▸ MAPT P10636 4/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ STAT1 P42224 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ TTK P33981 1/20 0.37
▸ PKM P14618 2/20 0.37
▸ ALPL P05186 1/20 0.37
▸ ALPI P09923 1/20 0.37
▸ LMNA P02545 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ PKLR P30613 1/20 0.36
▸ MAPK1 P28482 1/20 0.35
▸ CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15973035 0.79 ROCK2 (0.48) ROCK2PDE2ANPSR1RXFP1ALDH1A1
SCHEMBL15240439 0.79 ROCK2 (0.48) ROCK2PDE2ANPSR1RXFP1ALDH1A1
SCHEMBL18901296 0.79 ROCK2 (0.51) ROCK2PDE2ANPSR1RXFP1ALDH1A1
SCHEMBL15972991 0.77 MEN1 (0.52) ROCK2PDE2AMAPTPOLBLMNA
SCHEMBL16377287 0.77 ROCK2 (0.46) ROCK2PDE2ANPSR1RXFP1ALDH1A1
SCHEMBL11209858 0.75 MAPT (0.70) ROCK2RXFP1ALDH1A1MAPTKDM4E
SCHEMBL16345023 0.75 ROCK2 (0.63) ROCK2PDE2A
SCHEMBL6856438 0.75 CYP2A6 (0.45) ALDH1A1MAPTKDM4ERAB9ALMNA
SCHEMBL30367521 0.75 CYP2A6 (0.45) ALDH1A1MAPTKDM4ERAB9ALMNA
SCHEMBL10816890 0.74 KMT2A (0.50) ROCK2NPSR1RXFP1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3016951-B1 TRICYCLIC PYRIDO-CARBOXAMIDE DERIVATIVES AS ROCK INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-05-31 — — EP disclosed
Send feedback